Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial - Top-Institutions - MDSpire

Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial

  • By

  • Prasanna Jagannathan

  • Haley Hedlin

  • Jane W Liang

  • Blake Shaw

  • Evan Maestri

  • Michelle Lin

  • P J Utz

  • Upinder Singh

  • Linda N Geng

  • Hector Bonilla

  • October 8, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Clinical Trials
    • Immunology
    • Post-Acute COVID-19 Syndrome

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Post-Infectious Syndromes
    • Clinical Research
    • Multidisciplinary Care

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Pulmonary Medicine
    • Clinical Epidemiology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Neurology
    • Patient-Reported Outcomes Research

  • #5

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Pulmonary and Critical Care Medicine
    • Clinical Trials

Original Source(s)

Longitudinal Patient-Reported Outcome Trajectories in Long COVID: Findings From the STOP-PASC Clinical Trial

  • by Prasanna Jagannathan, Haley Hedlin, Jane W Liang, Blake Shaw, Evan Maestri, Michelle Lin, P J Utz, Upinder Singh, Linda N Geng, Hector Bonilla

  • October 8, 2025

Related Content

Self-administered digital vaccination decision-aids in primary care: A pilot study of COVID-19 vaccination in Atlanta, GA

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra